Background: Bethanechol chloride, a cholinergic agonist, is often prescribed in suspected underactive bladders to improve detrusor contractility, despite its limited clinical efficacy. We investigated the usage pattern of bethanechol in actual practice with the understanding that it would enable the physicians to make an informed decision on the coherent use of bethanechol. Methods: Anation-wide survey was carried out to obtain the responses of the urologists.Out of the 755 urologists approached, 630 survey responses were considered for analysis. Results: Usage of bethanechol was advocated as very common [318 (50.48%)], common [200 (31.75%)], not so common [107 (16.98%)], and rare [5 (0.79%)] in postoperative urinary retention, where it was preferred either exclusively [255 (40.48%)] or along with alpha blockers [247 (39.21%)]. Predilection to use alpha-blocker [247 (39.21%)], alpha-blocker plus naloxone [4 (0.64%)], naloxone [1 (0.16%)], alpha-blocker plus bethanechol plus naloxone [1 (0.16%)] was also observed. It was also preferred individually in pathologies causing urinary retention such as benign prostatic hyperplasia [125 (19.84%)], diabetic neuropathy [82 (13.02%)], neurological diseases [69 (10.95%)], senile bladder [14 (2.22%)], drugs [13 (2.06%)], and infective/inflammatory conditions [6 (0.95%)]. Other [321 (50.95%)] physicians opted to prescribe bethanechol in two or more of the enumerated indications. Bethanechol was prescribed orally as 25 mg thrice daily [441 (70.00%)], 50 mg thrice daily [86 (13.65%)], 25 mg four times daily [59 (9.37%)], and many “strongly agree” and “agree” that its sustained release formulation may offer better treatment compliance [565 (89.68%)], safety [548 (86.99%)], and efficacy [544 (86.35%)]. Conclusion: Bethanechol was the most prescribed drug for the management of postoperative urinary retention and other pathologies suspected to cause underactive bladder.
References
[1]
Gani, J. and Hennessey, D. (2017) The Underactive Bladder: Diagnosis and Surgical Treatment Options. Translational Andrology and Urology, 6, S186-S195. http://dx.doi.org/10.21037/tau.2017.04.07
[2]
Webb, R.J., Lawson, A.L. and Neal, D.E. (1990) Clean Intermittent Self-Catheterisation in 172 Adults. British Journal of Urology, 65, 20-23. https://doi.org/10.1111/j.1464-410X.1990.tb14653.x
[3]
Bayrak, Ö. and Dmochowski, R.R. (2019) Underactive Bladder: A Review of the Current Treatment Concepts. Turkish Journal of Urology, 45, 401-409.
[4]
Diokno, A.C. and Koppenhoefer, R. (1976) Bethanechol Chloride in Neurogenic Bladder Dysfunction. Urology, 8, 455-458. http://dx.doi.org/10.1016/0090-4295(76)90274-0
[5]
Barendrecht, M.M., Oelke, M., Laguna, M.P. and Michel, M.C. (2007) Is the Use of Parasympathomimetics for Treating an Underactive Urinary Bladder Evidence-Based? BJU International, 99, 749-752. https://doi.org/10.1111/j.1464-410X.2006.06742.x
[6]
Gaitonde, S., Malik, R.D., Christie, A.L. and Zimmern, P.E. (2019) Bethanechol: Is It Still Being Prescribed for Bladder Dysfunction in Women? TheInternational Journal of Clinical Practice, 73, e13248. https://doi.org/10.1111/ijcp.13248
[7]
Akkoc, A., Aydin, C., Topaktas, R., Kartalmis, M., Altin, S., Isen, K., et al. (2016) Prophylactic Effects of Alpha-Blockers, Tamsulosin and Alfuzosin, on Postoperative Urinary Retention in Male Patients Undergoing Urologic Surgery under Spinal Anaesthesia. International Brazilian Journal of Urology, 42, 578-584. https://doi.org/10.1590/S1677-5538.IBJU.2015.0256
[8]
Gill, S., Singh, R. and Singh, N.R. (2020) Effect of Silodosin in Post Operative Retention of Urine. International Surgery Journal,7, 1378-1384. https://doi.org/10.18203/2349-2902.isj20201562
[9]
Yamanishi, T., Yasuda, K., Kamai, T., Tsujii, T., Sakakibara, R., Uchiyama, T., et al. (2004) Combination of a Cholinergic Drug and an Alpha-Blocker Is More Effective than Monotherapy for the Treatment of Voiding Difficulty in Patients with Underactive Detrusor. International Journal of Urology, 11, 88-96. https://doi.org/10.1111/j.1442-2042.2004.00753.x
[10]
Turan, A., Fang, J., Esa, W.A.S., Hamadnalla, H., Leung, S., Pu, X., et al. (2022) Naloxegol and Postoperative Urinary Retention: A Randomized Trial. Journal of Clinical Medicine, 11, No. 454. https://doi.org/10.3390/jcm11020454
Fusco, F., Creta, M., De Nunzio. C., Lacovelli, V., Mangiapia, F., Marzi, V.L., et al. (2018) Progressive Bladder Remodeling Due to Bladder Outlet Obstruction: A Systematic Review of Morphological and Molecular Evidences in Humans. BMC Urology, 18, Article No. 15. https://doi.org/10.1186/s12894-018-0329-4
[13]
Creta, M., Ruvolo, C.C., Longo, N., Mangiapia, F., Arcaniolo, D., Sio, M.D.E., et al. (2021) Detrusor Overactivity and Underactivity: Implication for Lower Urinary Tract Symptoms Related to Benign Prostate Hyperplasia Diagnosis and Treatment. Minerva Urology and Nephrology, 73, 59-71.
[14]
Kebapci, N., Yenilmez, A., Efe, B., Entok, E. and Demirustu, C. (2007) Bladder Dysfunction in Type 2 Diabetic Patients. Neurourology Urodynamics, 26, 814-819. https://doi.org/10.1002/nau.20422
[15]
Golbidi, S. and Laher, I. (2010) Bladder Dysfunction in Diabetes Mellitus. Frontiers in Pharmacology, 1, Article No. 136. https://doi.org/10.3389/fphar.2010.00136
[16]
Kaplan, S.A., Te, A.E. and Blaivas, J.G. (1995) Urodynamic Findings in Patients with Diabetic Cystopathy. The Journal of Urology, 153, 342-344. https://doi.org/10.1097/00005392-199502000-00013
[17]
Loiudice, T.A. and Buhac, I. (1977) Diabetic Visceral Neuropathy: Treatment with Bethanechol Chloride. Southern Medical Journal, 70, 253-254.
[18]
Resnick, N.M. and Yalla, S.V. (1987) Detrusor Hyperactivity with Impaired Contractile Function. An Unrecognized but Common Cause of Incontinence in Elderly Patients. The Journal of the American Medical Association, 257, 3076-3081.
[19]
Malone-Lee, J. and Wahedna, I. (1993) Characterisation of Detrusor Contractile Function in Relation to Old Age. British Journal of Urology, 72, 873-880. https://doi.org/10.1111/j.1464-410X.1993.tb16289.x
[20]
Lepor, H., Sunaryade, I., Hartanto, V. and Shapiro, E. (1992) Quantitative Morphology of the Adult Human Bladder. Journal of Urology, 148, 414-417. https://doi.org/10.1016/S0022-5347(17)36619-3
[21]
Hald, T. and Horn, T. (1998) The Human Urinary Bladder in Aging. British Journal of Urology, 82, 59-64. https://doi.org/10.1046/j.1464-410X.1998.0820s1059.x
[22]
Siroky, M.B. (2004) The Aging Bladder. Reviews in Urology, 6, S3-S7.
[23]
Madersbacher, S., Pycha, A., Schatzl, G., Mian, C., Klingler, C.H. and Marberger, M. (1998) The Aging Lower Urinary Tract: A Comparative Urodynamic Study of Men And women. Urology, 51, 206-212. https://doi.org/10.1016/S0090-4295(97)00616-X
[24]
Miyazato, M., Yoshimura, N. and Chancellor, M.B. (2013) The Other Bladder Syndrome: Underactive Bladder. Reviews in Urology, 15, 11-22.
[25]
Fudaba, H., Ooba, H., Abe, T., Kamida, T., Wakabayashi, Y., Nagatomi, H., et al. (2014) An Adult Case of Cerebral Malakoplakia Successfully Cured by Treatment with Antibiotics, Bethanechol and Ascorbic Acid. Journal of the Neurological Sciences, 342, 192-196. https://doi.org/10.1016/j.jns.2014.05.006
